[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
TISSUE=Kidney;
PubMed=7679927 [NCBI, ExPASy, EBI, Israel, Japan]
Palmer C.N.A.,
Richardson T.H.,
Griffin K.J.,
Hsu M.-H.,
Muerhoff A.S.,
Clark J.E.,
Johnson E.F.;
"Characterization of a cDNA encoding a human kidney, cytochrome P-450 4A fatty acid omega-hydroxylase and the cognate enzyme expressed in Escherichia coli.";
Biochim. Biophys. Acta 1172:161-166(1993).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 5-24, AND CHARACTERIZATION.
TISSUE=Liver;
PubMed=7798189 [NCBI, ExPASy, EBI, Israel, Japan]
Kawashima H.,
Kusunose E.,
Kikuta Y.,
Kinoshita H.,
Tanaka S.,
Yamamoto S.,
Kishimoto T.,
Kusunose M.;
"Purification and cDNA cloning of human liver CYP4A fatty acid omega-hydroxylase.";
J. Biochem. 116:74-80(1994).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT SER-434, AND CHARACTERIZATION.
TISSUE=Kidney;
PubMed=8274222 [NCBI, ExPASy, EBI, Israel, Japan]
Imaoka S.,
Ogawa H.,
Kimura S.,
Gonzalez F.J.;
"Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid omega-hydroxylase expressed in human kidney.";
DNA Cell Biol. 12:893-899(1993).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
DOI=10.1016/S0003-9861(02)00545-3; PubMed=12464262 [NCBI, ExPASy, EBI, Israel, Japan]
Bellamine A.,
Wang Y.,
Waterman M.R.,
Gainer J.V. III,
Dawson E.P.,
Brown N.J.,
Capdevila J.H.;
"Characterization of the CYP4A11 gene, a second CYP4A gene in humans.";
Arch. Biochem. Biophys. 409:221-227(2003).
|
[5]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT SER-434.
SeattleSNPs program for genomic applications;
Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature04727; PubMed=16710414 [NCBI, ExPASy, EBI, Israel, Japan]
Gregory S.G.,
Barlow K.F.,
McLay K.E.,
Kaul R.,
Swarbreck D.,
Dunham A.,
Scott C.E.,
Howe K.L.,
Woodfine K.,
Spencer C.C.A.,
Jones M.C.,
Gillson C.,
Searle S.,
Zhou Y.,
Kokocinski F.,
McDonald L.,
Evans R.,
Phillips K.,
Atkinson A., ![]()
Cooper R.,
Jones C.,
Hall R.E.,
Andrews T.D.,
Lloyd C.,
Ainscough R.,
Almeida J.P.,
Ambrose K.D.,
Anderson F.,
Andrew R.W.,
Ashwell R.I.S.,
Aubin K.,
Babbage A.K.,
Bagguley C.L.,
Bailey J.,
Beasley H.,
Bethel G.,
Bird C.P.,
Bray-Allen S.,
Brown J.Y.,
Brown A.J.,
Buckley D.,
Burton J.,
Bye J.,
Carder C.,
Chapman J.C.,
Clark S.Y.,
Clarke G.,
Clee C.,
Cobley V.,
Collier R.E.,
Corby N.,
Coville G.J.,
Davies J.,
Deadman R.,
Dunn M.,
Earthrowl M.,
Ellington A.G.,
Errington H.,
Frankish A.,
Frankland J.,
French L.,
Garner P.,
Garnett J.,
Gay L.,
Ghori M.R.J.,
Gibson R.,
Gilby L.M.,
Gillett W.,
Glithero R.J.,
Grafham D.V.,
Griffiths C.,
Griffiths-Jones S.,
Grocock R.,
Hammond S.,
Harrison E.S.I.,
Hart E.,
Haugen E.,
Heath P.D.,
Holmes S.,
Holt K.,
Howden P.J.,
Hunt A.R.,
Hunt S.E.,
Hunter G.,
Isherwood J.,
James R.,
Johnson C.,
Johnson D.,
Joy A.,
Kay M.,
Kershaw J.K.,
Kibukawa M.,
Kimberley A.M.,
King A.,
Knights A.J.,
Lad H.,
Laird G.,
Lawlor S.,
Leongamornlert D.A.,
Lloyd D.M.,
Loveland J.,
Lovell J.,
Lush M.J.,
Lyne R.,
Martin S.,
Mashreghi-Mohammadi M.,
Matthews L.,
Matthews N.S.W.,
McLaren S.,
Milne S.,
Mistry S.,
Moore M.J.F.,
Nickerson T.,
O'Dell C.N.,
Oliver K.,
Palmeiri A.,
Palmer S.A.,
Parker A.,
Patel D.,
Pearce A.V.,
Peck A.I.,
Pelan S.,
Phelps K.,
Phillimore B.J.,
Plumb R.,
Rajan J.,
Raymond C.,
Rouse G.,
Saenphimmachak C.,
Sehra H.K.,
Sheridan E.,
Shownkeen R.,
Sims S.,
Skuce C.D.,
Smith M.,
Steward C.,
Subramanian S.,
Sycamore N.,
Tracey A.,
Tromans A.,
Van Helmond Z.,
Wall M.,
Wallis J.M.,
White S.,
Whitehead S.L.,
Wilkinson J.E.,
Willey D.L.,
Williams H.,
Wilming L.,
Wray P.W.,
Wu Z.,
Coulson A.,
Vaudin M.,
Sulston J.E.,
Durbin R.M.,
Hubbard T.,
Wooster R.,
Dunham I.,
Carter N.P.,
McVean G.,
Ross M.T.,
Harrow J.,
Olson M.V.,
Beck S.,
Rogers J.,
Bentley D.R.;
"The DNA sequence and biological annotation of human chromosome 1.";
Nature 441:315-321(2006).
|
[7]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
TISSUE=Colon;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[8]
|
PARTIAL PROTEIN SEQUENCE OF 5-39, AND CHARACTERIZATION.
TISSUE=Kidney;
DOI=10.1016/0005-2760(92)90106-6; PubMed=1739747 [NCBI, ExPASy, EBI, Israel, Japan]
Kawashima H.,
Kusunose E.,
Kubota I.,
Maekawa M.,
Kusunose M.;
"Purification and NH2-terminal amino acid sequences of human and rat kidney fatty acid omega-hydroxylases.";
Biochim. Biophys. Acta 1123:156-162(1992).
|
[9]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 317-457, AND VARIANTS GLY-353 AND SER-434.
TISSUE=Liver;
PubMed=8363569 [NCBI, ExPASy, EBI, Israel, Japan]
Bell D.R.,
Plant N.J.,
Rider C.G.,
Na L.,
Brown S.,
Ateitalla I.,
Acharya S.K.,
Davies M.H.,
Elias E.E.,
Jenkins N.A.,
Gilbert D.J.,
Copeland N.G.,
Elcombe C.R.;
"Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs.";
Biochem. J. 294:173-180(1993).
|
[10]
|
COVALENT HEME ATTACHMENT.
DOI=10.1074/jbc.M009969200; PubMed=11139583 [NCBI, ExPASy, EBI, Israel, Japan]
Hoch U.,
Ortiz de Montellano P.R.;
"Covalently linked heme in cytochrome P4504A fatty acid hydroxylases.";
J. Biol. Chem. 276:11339-11346(2001).
|
[11]
|
COVALENT HEME ATTACHMENT, AND MUTAGENESIS OF GLU-321.
DOI=10.1074/jbc.M112155200; PubMed=11821421 [NCBI, ExPASy, EBI, Israel, Japan]
LeBrun L.A.,
Hoch U.,
Ortiz de Montellano P.R.;
"Autocatalytic mechanism and consequences of covalent heme attachment in the cytochrome P4504A family.";
J. Biol. Chem. 277:12755-12761(2002).
|
[12]
|
FUNCTION, MUTAGENESIS OF GYL-130, AND VARIANT SER-434.
DOI=10.1161/01.CIR.0000151309.82473.59; PubMed=15611369 [NCBI, ExPASy, EBI, Israel, Japan]
Gainer J.V.,
Bellamine A.,
Dawson E.P.,
Womble K.E.,
Grant S.W.,
Wang Y.,
Cupples L.A.,
Guo C.-Y.,
Demissie S.,
O'Donnell C.J.,
Brown N.J.,
Waterman M.R.,
Capdevila J.H.;
"Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension.";
Circulation 111:63-69(2005).
|
[13]
|
VARIANTS GLY-353 AND SER-434.
DOI=10.1007/s10038-005-0245-9; PubMed=15895287 [NCBI, ExPASy, EBI, Israel, Japan]
Cho B.H.,
Park B.L.,
Kim L.H.,
Chung H.S.,
Shin H.D.;
"Highly polymorphic human CYP4A11 gene.";
J. Hum. Genet. 50:259-263(2005).
|
|
ExPASy Home page
SIB Switzerland
